Evaluating the glucose tolerance test in mice.

The objective of this study was to determine the optimal conditions under which to assess glucose tolerance in chow- and high-fat-fed C57BL/6J mice. Mice were fed either chow or high-fat diet for 8 wk. Variables tested were fasting duration (0-, 3-, 6-, and 24-h and overnight fasting), route of administration (intraperitoneal vs. oral) load of glucose given (2, 1, or 0.5 g/kg and fixed 50-mg dose), and state of consciousness. Basal glucose concentrations were increased in high-fat- compared with chow-fed mice following 6 h of fasting (9.1 +/- 0.3 vs. 7.9 +/- 0.4 mmol/l P = 0.01). Glucose tolerance was most different and therefore significant (P = 0.001) in high-fat-fed mice after 6 h of fasting (1,973 +/- 96 vs. 1,248 +/- 83 mmol.l(-1).120 min(-1)). The difference in glucose tolerance was greater following an OGTT (142%), in contrast to an IPGTT, with a 127% difference between high fat and chow. We also found that administering 2 g/kg of glucose resulted in a greater level of significance (P = 0.0008) in glucose intolerance in high-fat- compared with chow-fed mice. A fixed dose of 50 mg glucose regardless of body weight was enough to show glucose intolerance in high-fat- vs. chow-fed mice. Finally, high-fat-fed mice showed glucose intolerance compared with their chow-fed counterparts whether they were tested under conscious or anesthetized conditions. We conclude that 2 g/kg glucose administered orally following 6 h of fasting is best to assess glucose tolerance in mice under these conditions.

[1]  M. Katze,et al.  Pancreatic (cid:1) -Cell Failure and Diabetes in Mice With a Deletion Mutation of the Endoplasmic Reticulum Molecular Chaperone Gene P58 IPK , 2022 .

[2]  G. Shulman,et al.  Overexpression of Glut4 protein in muscle increases basal and insulin-stimulated whole body glucose disposal in conscious mice. , 1995, The Journal of clinical investigation.

[3]  J. Proietto,et al.  Metabolic adaptations of three inbred strains of mice (C57BL/6, DBA/2, and 129T2) in response to a high-fat diet. , 2004, The Journal of nutrition.

[4]  S. Kahn,et al.  beta-cell glucokinase deficiency and hyperglycemia are associated with reduced islet amyloid deposition in a mouse model of type 2 diabetes. , 2000, Diabetes.

[5]  R. Muniyappa,et al.  Comparison between surrogate indexes of insulin sensitivity/resistance and hyperinsulinemic euglycemic clamp estimates in rats. , 2008, American journal of physiology. Endocrinology and metabolism.

[6]  V. Arioli,et al.  Errors related to different techniques of intraperitoneal injection in mice. , 1970, Applied microbiology.

[7]  V. Mootha,et al.  Abnormal glucose homeostasis in skeletal muscle–specific PGC-1α knockout mice reveals skeletal muscle–pancreatic β cell crosstalk , 2007 .

[8]  A. Thorburn,et al.  Comparison of Insulin Secretory Function in Two Mouse Models with Different Susceptibility to β-Cell Failure. , 2002, Endocrinology.

[9]  S. Kahn,et al.  Mechanisms linking obesity to insulin resistance and type 2 diabetes , 2006, Nature.

[10]  G. Cooney,et al.  Inhibition of PKCɛ Improves Glucose-Stimulated Insulin Secretion and Reduces Insulin Clearance , 2007 .

[11]  C. Kahn,et al.  Glucose homeostasis and tissue transcript content of insulin signaling intermediates in four inbred strains of mice: C57BL/6, C57BLKS/6, DBA/2, and 129X1. , 2004, Endocrinology.

[12]  Frank J. Gonzalez,et al.  Loss of ARNT/HIF1β Mediates Altered Gene Expression and Pancreatic-Islet Dysfunction in Human Type 2 Diabetes , 2005, Cell.

[13]  O. McGuinness,et al.  Considerations in the design of hyperinsulinemic-euglycemic clamps in the conscious mouse. , 2006, Diabetes.

[14]  Senta Georgia,et al.  Essential role of Skp2-mediated p27 degradation in growth and adaptive expansion of pancreatic beta cells. , 2007, The Journal of clinical investigation.

[15]  G. Pacini,et al.  Insufficient islet compensation to insulin resistance vs. reduced glucose effectiveness in glucose-intolerant mice. , 2002, American journal of physiology. Endocrinology and metabolism.

[16]  G. Morahan,et al.  Increased nicotinamide nucleotide transhydrogenase levels predispose to insulin hypersecretion in a mouse strain susceptible to diabetes , 2007, Diabetologia.

[17]  D. Wasserman,et al.  Overexpression of hexokinase II increases insulinand exercise-stimulated muscle glucose uptake in vivo. , 1999, American journal of physiology. Endocrinology and metabolism.

[18]  V. Mootha,et al.  Abnormal glucose homeostasis in skeletal muscle-specific PGC-1alpha knockout mice reveals skeletal muscle-pancreatic beta cell crosstalk. , 2007, The Journal of clinical investigation.

[19]  S. Kahn,et al.  - Cell Glucokinase Deficiency and Hyperglycemia Are Associated With Reduced Islet Amyloid Deposition in a Mouse Model of Type 2 Diabetes , 2000 .

[20]  B. Ahrén,et al.  The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes. , 2004, Diabetes.

[21]  G. Pacini,et al.  The augmenting effect on insulin secretion by oral versus intravenous glucose is exaggerated by high-fat diet in mice. , 2008, The Journal of endocrinology.

[22]  G. Cooney,et al.  Inhibition of PKCepsilon improves glucose-stimulated insulin secretion and reduces insulin clearance. , 2007, Cell metabolism.

[23]  A. Thorburn,et al.  Comparison of insulin secretory function in two mouse models with different susceptibility to beta-cell failure. , 2002, Endocrinology.

[24]  R. Muniyappa,et al.  Comparison between surrogate indexes of insulin sensitivity and resistance and hyperinsulinemic euglycemic clamp estimates in mice. , 2008, American journal of physiology. Endocrinology and metabolism.

[25]  J. Romijn,et al.  Sixteen hours of fasting differentially affects hepatic and muscle insulin sensitivity in mice Published, JLR Papers in Press, December 1, 2004. DOI 10.1194/jlr.M400440-JLR200 , 2005, Journal of Lipid Research.

[26]  S. Kahn,et al.  Differential effect of inbred mouse strain (C57BL/6, DBA/2, 129T2) on insulin secretory function in response to a high fat diet. , 2005, The Journal of endocrinology.

[27]  Jenny E Gunton,et al.  Loss of ARNT/HIF1beta mediates altered gene expression and pancreatic-islet dysfunction in human type 2 diabetes. , 2005, Cell.

[28]  P. Bénit,et al.  Targeted Deletion of AIF Decreases Mitochondrial Oxidative Phosphorylation and Protects from Obesity and Diabetes , 2007, Cell.

[29]  S. Andrikopoulos,et al.  6 The New Zealand Obese Mouse: Polygenic Model of Obesity, Glucose Intolerance, and the Metabolic Syndrome , 2007 .

[30]  R. Larkins,et al.  Evolution of Insulin Resistance in New Zealand Obese Mice , 1991, Diabetes.

[31]  N. A. Miner,et al.  Intraperitoneal Injection of Mice , 1969, Applied microbiology.

[32]  B. Lowell,et al.  Glucose sensing by POMC neurons regulates glucose homeostasis and is impaired in obesity , 2007, Nature.

[33]  D. R. Laybutt,et al.  Fructose-1,6-bisphosphatase overexpression in pancreatic beta-cells results in reduced insulin secretion: a new mechanism for fat-induced impairment of beta-cell function. , 2008, Diabetes.

[34]  F. Sundler,et al.  Dissociated insulinotropic sensitivity to glucose and carbachol in high-fat diet-induced insulin resistance in C57BL/6J mice. , 1997, Metabolism: clinical and experimental.

[35]  A. Depaoli-Roach,et al.  Glucose metabolism in mice lacking muscle glycogen synthase. , 2005, Diabetes.

[36]  C. Ling,et al.  Enhanced mitochondrial metabolism may account for the adaptation to insulin resistance in islets from C57BL/6J mice fed a high-fat diet , 2006, Diabetologia.

[37]  D. R. Laybutt,et al.  Fructose-1,6-Bisphosphatase Overexpression in Pancreatic β-Cells Results in Reduced Insulin Secretion , 2008, Diabetes.

[38]  J. Proietto,et al.  Expression of human fructose-1,6-bisphosphatase in the liver of transgenic mice results in increased glycerol gluconeogenesis. , 2006, Endocrinology.

[39]  B. Doble,et al.  Glycogen synthase kinase 3alpha-specific regulation of murine hepatic glycogen metabolism. , 2007, Cell metabolism.